Cleveland Clinic Rheumatology

Cleveland Clinic offers expert diagnosis, treatment and rehabilitation for bone, joint or connective tissue disorders and rheumatic and immunologic diseases.

Understanding B and T Cell Targeting in Autoimmune Diseases: Is Belimumab The Only FDA Approved Agent for SLE? What are the Roles of B Cells in Autoimmune Pathogenesis and Which Approaches do we have to Eliminate Them?

By Cleveland Clinic Rheumatology FEATURING Gregg Silverman

15 views

July 30, 2020

Comments 0

Login

Login

Join VuMedi

Cleveland Clinic Rheumatology

Understanding B and T Cell Targeting in Autoimmune Diseases: Is Belimumab The Only FDA Approved Agent for SLE? What are the Roles of B Cells in Autoimmune Pathogenesis and Which Approaches do we have to Eliminate Them?

SLE Management: What Are the New Agents That Have Been Approved or H…

SLE: New Perspectives on Pathogenesis and Emerging Novel Therapies

Eye Disorders in Rheumatic Diseases: What Are the Recommendations on…

SLE With High Disease Activity & Potential Therapeutic Targets: Shou…

Managing Dermatologic Conditions in Rheumatology: How to Recognize a…

Advances in the Laboratory Aspects of Basic and Clinical Immunology …

A Primer on the Microbiome and Immune Health and Disease

Immunology for the Non-Immunologist: Understanding Immunology When Y…

Understanding B and T Cell Targeting in Autoimmune Diseases: Is Beli…

New and Emerging Treatments of Cutaneous Lupus

Advances in SLE and Vasculitis

Kinase Inhibition for IMIDs